Millennium Management LLC Has $253.18 Million Holdings in Ralliant Corporation $RAL

Millennium Management LLC increased its holdings in Ralliant Corporation (NYSE:RAL) by 172.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,973,001 shares of the company’s stock after acquiring an additional 3,147,660 shares during the period. Millennium Management LLC owned about 4.41% of Ralliant worth $253,175,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Phocas Financial Corp. grew its stake in shares of Ralliant by 81.2% in the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock worth $7,999,000 after acquiring an additional 70,403 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock worth $637,995,000 after acquiring an additional 1,415,327 shares in the last quarter. SG Capital Management LLC bought a new stake in shares of Ralliant in the 3rd quarter worth $8,139,000. Victory Capital Management Inc. grew its stake in shares of Ralliant by 1,726.7% in the 3rd quarter. Victory Capital Management Inc. now owns 873,794 shares of the company’s stock worth $38,211,000 after acquiring an additional 825,960 shares in the last quarter. Finally, Clean Energy Transition LLP grew its stake in shares of Ralliant by 70.1% in the 3rd quarter. Clean Energy Transition LLP now owns 900,903 shares of the company’s stock worth $39,396,000 after acquiring an additional 371,419 shares in the last quarter.

Ralliant Price Performance

Shares of NYSE:RAL opened at $67.50 on Thursday. The company’s 50-day moving average is $54.62 and its 200 day moving average is $50.26. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. The company has a market capitalization of $7.56 billion and a P/E ratio of -6.17. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $70.22.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08. The company had revenue of $534.60 million for the quarter. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. Ralliant’s quarterly revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, equities research analysts forecast that Ralliant Corporation will post 2.64 earnings per share for the current year.

Ralliant Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s payout ratio is -1.83%.

Analyst Ratings Changes

Several analysts have recently issued reports on RAL shares. Barclays upped their target price on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 13th. Citigroup upped their target price on shares of Ralliant from $51.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Royal Bank Of Canada upped their target price on shares of Ralliant from $47.00 to $64.00 and gave the stock a “sector perform” rating in a research note on Wednesday, May 13th. Truist Financial reiterated a “buy” rating and issued a $68.00 target price (up from $53.00) on shares of Ralliant in a research note on Wednesday, May 13th. Finally, Zacks Research upgraded shares of Ralliant from a “strong sell” rating to a “hold” rating in a research note on Monday, April 13th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $67.30.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.